Visual evoked potentials in multiple sclerosis before and after two years of interferon therapy

Area of Science:

• Neuroscience
• Clinical Neurology
• Medical Imaging

Background:

• Magnetic resonance imaging (MRI) is crucial for multiple sclerosis (MS) diagnosis and treatment monitoring.
• Evoked potentials offer an alternative or complementary diagnostic tool when MRI is inconclusive or unavailable.

Purpose of the Study:

• To assess the utility of serial visual evoked potentials (VEPs) and cranial MRI in monitoring relapsing-remitting multiple sclerosis (MS) patients undergoing interferon beta-1b (IFNβ-1b) therapy.
• To determine if VEPs can serve as a reliable electrophysiological index for tracking disease progression during interferon treatment.

Main Methods:

• Serial VEPs and cranial MRI were performed on 15 MS patients and 15 healthy controls before IFNβ-1b therapy, at 1 year, and at 2 years (10 patients).
• P100 latency was used as the electrophysiological index to evaluate disease progression.
• Comparisons were made between baseline, 1-year, and 2-year VEP and MRI findings.

Main Results:

• All patients exhibited abnormal MRI findings.
• Most MS patients presented with abnormal VEPs.
• Significant differences in VEPs were observed between the start and end of interferon treatment, indicating treatment effects.

Conclusions:

• VEPs are a valuable and reliable electrophysiological index for monitoring the progress of multiple sclerosis (MS) in patients treated with interferon therapy.
• VEPs provide complementary information to MRI in the management of MS.
• Serial VEP assessments can help track treatment efficacy and disease activity over time.